Molecular genetics of B-precursor acute lymphoblastic leukemia
Open accessThe DOI matches its Crossref record; 126 of the 127 references it cites were found in a registry or an index.
Abstract
B-precursor acute lymphoblastic leukemia (B-ALL) is the most common childhood tumor and the leading cause of cancer-related death in children and young adults. The majority of B-ALL cases are aneuploid or harbor recurring structural chromosomal rearrangements that are important initiating events in leukemogenesis but are insufficient to explain the biology and heterogeneity of disease. Recent studies have used microarrays and sequencing to comprehensively identify all somatic genetic alterations in acute lymphoblastic leukemia (ALL). These studies have identified cryptic or submicroscopic genetic alterations that define new ALL subtypes, cooperate with known chromosomal rearrangements, and influence prognosis. This article reviews these advances, discusses results from ongoing second-generation sequencing studies of ALL, and highlights challenges and opportunities for future genetic profiling approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“BCP-ALL, which is characterized by a block in lymphoid differentiation leading to the accumulation of immature progenitor cells.37”
From PELI2 regulates early B-cell progenitor differentiation and related leukemia via the IL-7R expression (2023) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243 · cited 1×
“org Volume 122 Number 10 October 2012 3409 such as imatinib mesylate (Gleevec) have transformed the treatment and outcome of patients with BCR-ABL1–positive leukemia (40, 41).”
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713 · cited 1×
“org Volume 122 Number 10 October 2012 3409 such as imatinib mesylate (Gleevec) have transformed the treatment and outcome of patients with BCR-ABL1–positive leukemia (40, 41).”
Yeoh, E.-J., Ross, M. E., Shurtleff, S. A., Williams, W. K., Patel, D., Mahfouz, R., Behm, F. G., Raimondi, S. C., Relling, M. V., Patel, A., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00032-6 · Cited by 1,917 · cited 1×
“These approaches, coupled with candidate gene sequencing and integrated gene expression profiling (92), have identified a number of critical new targets of mutation in B-ALL that often involve genes that regulate lymphoid development, cell cycle, tumor suppression, and a variety of other key…”
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan-Smith, E., Dalton, J. D., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,801 · cited 6×
“The nature and frequency of these CNAs are significantly associated with ALL subtype, with few lesions in MLL-rearranged ALL (17, 55) but 6–8 lesions per case in BCR-ABL1 and ETV6-RUNX1 ALL (33, 34).”
InfluentialSelf-citationCBP/p300 in cell growth, transformation, and development
Goodman, R. H., & Smolik, S. (2000) · Genes & Development · doi:10.1101/gad.14.13.1553 · Cited by 1,778
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M. L., Minden, M. D., Sallan, S. E., Lander, E. S., Golub, T. R., & Korsmeyer, S. J. (2002) · Nature Genetics · doi:10.1038/ng765 · Cited by 1,723
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
Self-citationPui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422 · cited 2×
“Despite their high frequency of occurrence, PAX5 alterations are not associated with outcome in ALL (81, 95).”
Self-citation
Research works printed but not linked: 2
- Andersson AK, et al. Whole genome sequence anal- ysis of 22 MLL rearranged infant acute lympho- blastic leukemias reveals remarkably few somatic mutations: a report from the St. Jude Children's Research Hospital -Washington University Pedi- atric Cancer Genome Project. ASH Annual Meeting Abstracts. 2011;118:69.
- Mullighan, 2007, 110, 691
Cited by
Items 201–261 of 261
Impact of Phototherapy on Childhood Cancer: A Comprehensive Systematic Review and Meta-analysis
Galdós-Bejar, M., Belanovic-Ramirez, I., Baquedano-Rojas, C., Alarcón-Espinosa, J., Joya-Arista, V., Arrarte-Perez, A., & Orco-León, A. (2024) · Journal of Neonatology · doi:10.1177/09732179241304925 · Cited by 1
Akute lymphoblastische Leukämien (ALL) im Kindes- und Jugendalter
Attarbaschi, A., & Möricke, A. (2013) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-013-2911-x · Cited by 1
Opportunities for Targeting Gene Regulatory Factors in B-Cell Acute Lymphoblastic Leukemia
Ott, C. J. (2017) · International Journal of Hematologic Oncology · doi:10.2217/ijh-2017-0018 · Cited by 1
Willig, J. B. (2021) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 1
Minasi, L. B., Godoy, F. R., Silva, D. D. M. E., Gigonzac, T. C. V., da Silva, C. C., & da Cruz, A. D. (2013) · Tumor Biology · doi:10.1007/s13277-013-1192-2
MicroRNAs in Hematologic Malignancies
Bloehdorn, J., ROUHI, A. M., Dhanyamraju, P. K., Krowiorz, K., Schneider, E. M., Langer, C., Mertens, D., Stilgenbauer, S., & Kuchenbauer, F. C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8444-8_5
Podłoże molekularne i perspektywy terapeutyczne ostrej białaczki limfoblastycznej BCR-ABL1-like
Madzio, J., Pastorczak, A. K., & Mlynarski, W. M. (2014) · Cited by 1
Wilms tumor (WT)1 gene expression in children with acute leukemia in Serbia
Janković, S., Marjanović, I., Tos̆ić, N., Kotur, N., Dokmanović, L., Škorić, D., Krstovski, N., Lazić, J., Rodić, P., Pavlović, S., et al. (2016) · Genetika · doi:10.2298/gensr1601409j
“…of childhood leukemia, routine testing for genetic rearrangements TEL/AML1 (most common), E2A/PBX, MLL/AF4 and BCR/ABL for B-cell precursor ALL (MULLIGHAN, 2012); SIL/TAL1 for T-ALL; and PML/RARα, AML1-ETO, CBFB/MYH11, as well as FLT3 internal tandem duplication (ITD) for AML are routinely…”
BackgroundGENOME SEQUENCING AND ITS IMPACT ON HEMATOLOGY Genome sequencing of lymphoid malignancies
Mullighan, C. G. (2016)
Self-citation2. Cytogenetic and Genetic Abnormalities in Leukemia
Chiba, S. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.1661
Molecular Origin of Childhood Acute Lymphoblastic Leukemia
Waanders, E., Jongmans, M. C. J., & Mullighan, C. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-05798-9_7
Self-citationDOCTEUR DE L'UNIVERSITÉ DE RENNES 1
Arnaud, M.-P. (2015)
Host Genome Variation and Toxicity in Childhood Acute Lymphoblastic Leukaemia
Lund, B. (2014) · NORA - Norwegian Open Research Archives
Wafa, A., Ali, B. M., Aljapawe, A., Liehr, T., Almedani, S., & Achkar, W. A. (2017) · Gene Reports · doi:10.1016/j.genrep.2017.11.005
Papp, E. (2014) · TSpace (University of Toronto)
Characterization of oncogenic role of ROR1 and PTK7 in B-ALL
Hautanen, V. (2018) · Tampere University Institutional Repository (Tampere University)
Moreira, L. B. P. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-08012019-163609
Mei, E., Wei, X., Gao, J., Tian, X., Li, W., Liu, L., & Qian, C. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23414
Kilfoy, A. (2019) · TSpace (University of Toronto)
Quentmeier, H., Pommerenke, C., & Drexler, H. G. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43030149
“Focal deletions or sequence mutations of IKZF1 are recurrent in pediatric ALL [19].”
BackgroundInfluentialNucleolar RNAs and Proteins in Leukemia and Zebrafish Development
Teittinen, K. J. (2014) · Tampere University Institutional Repository (Tampere University)
Kornauth, C., Schiefer, A., & Simonitsch‐Klupp, I. (2019) · Springer eBooks · doi:10.1007/978-3-030-11769-6_7
Methods of prognostic factors detection in childhood acute lymphoblastic leukemia
Sędek, Ł. (2016) · Diagnostyka Laboratoryjna · doi:10.5604/01.3001.0008.2521
The role of calcium ions in the leukemic bone marrow microenvironment
Pereira, R. S. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.68681
Alanazi, M. A., Alzahrani, F., Shaikh, S. S., Msmar, A. H., & Hassan, F. M. (2023) · Electronic Journal of General Medicine · doi:10.29333/ejgm/13537
“genes that resulted from translocations by using fluorescent in situ hybridization (FISH) and real-time polymerase chain reaction (RT-PCR) [1, 2]; cytogenetic analysis also has a crucial role in determining the prognostic significance of B-ALL cases.”
MethodFregona, V. (2023) · theses.fr (ABES) · doi:10.70675/18ef589ez844fz4149za79az9124710af195 · Cited by 1
Pathak, G., Nigade, A., Purandare, D., Thorat, V. G., & Bhatt, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-3001-8_13
ความชุกของการเกิดยีนลูกผสมที่พบได้บ่อยในเด็กไทยที่เป็นมะเร็งเม็ดเลือดขาวแบบเฉียบพลันชนิด B-cell
Sriprach, S., & Takpradit, C. (2024) · Journal of Hematology and Transfusion Medicine (วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต) · doi:10.69898/jhtm.v34i3.271167
Common childhood cancers: Diagnostic and prognosis markers
Nayak, S., & Sriwastava, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23593-1.00006-5
Yi, J., Wu, M. P., Dowling, M. L., MacKenzie, A. C. E., Iansavitchous, J., & DeKoter, R. P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.19.629436
A discrete mathematical model of gene regulation in pediatric Acute Lymphoblastic Leukemia
Lacoste, V., Liso, A., Castiglione, F., & Jarrah, A. S. (2024) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm62325.2024.10822052
Rôle du microenvironnement inflammatoire dans les leucémies aiguës lymphoblastiques T
Maout, C. L. (2023) · theses.fr (ABES) · doi:10.70675/440b6ee0z663cz4473za54dz8e9f42487eb6
Studies on the Role of Transmembrane Proteins in Hemostasis
Deebani, A. (2024) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc2415951
Guo, Q., Xie, W., Fuentes, A., & Shuai, W. (2025) · Journal of Clinical and Translational Pathology · doi:10.14218/jctp.2025.00012
Deebani, A., Mary, J., Dhinoja, S., Qaryoute, A. A., Adhikary, R., Fallatah, W., & Jagadeeswaran, P. (2025) · Thrombosis and Haemostasis · doi:10.1055/a-2713-0711
Cao, X., Wang, Y., Kang, Y., Abubakar, M. U., Yang, Y., Fang, D., & He, B. (2025) · Global Medical Genetics · doi:10.1016/j.gmg.2025.100084
“IKZF1 encodes the early lymphoid transcription factor IKAROS, a key regulator of lymphocyte development and homeostasis [14,15].”
Ayaz Mahmood, S. K. (2018) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.1470626
Wafa, A., Jarjour, R. A., Alolabi, D., Liehr, T., Hamdan, O., Melo, J. B., Carreira, I. M., Othman, M. A. K., & Al-Achkar, W. (2020) · Figshare · doi:10.6084/m9.figshare.12947669
Rodrigues, L. (2023) · Lume (Universidade Federal do Rio Grande do Sul)
IKAROS Gene Regulatory Network Reveal ERG as a Vulnerability in B-cell Acute Lymphoblastic LeukemiaPreprint
Paculová, H., Richman, A. R., Boyd, J., Bernil, J. C., Rodriguez, P., Ayongaba, E. F., Ghule, P. N., Drivet, E., Palaria, A., Dajani, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.29.696402
Tan, K.-W., Xu, Y., Huang, Y.-H., Qiu, Q.-C., Lyu, X., Huang, S., Wang, Z.-H., Li, H., Xu, S.-Z., Liu, F.-T., et al. (2026) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2026.2621828
“…common ETV6 alteration, disrupts early B-cell differentiation, enhances survival and generally indicates favorable prognosis in pediatric B-ALL [11]. in contrast, IKZF1 alterations, particular deletions, are strongly linked to poor prognosis by causing developmental arrest and impaired B-cell…”
Reyes, D. F. R. (2021) · Universidad Industrial de Santander
Mohamed, A., Zabor, E. C., Patel, M., Zureigat, H., Alchirazi, M. A., & Ali, M. K. M. (2026) · JAP Academy Journal · doi:10.4103/japaj.japaj_59_25
Xiong, Y. (2016) · theses.fr (ABES) · doi:10.70675/47877607zde95z4ec4z83edz6faa02b0bb59 · Cited by 1
Nicoletti, S. (2017) · theses.fr (ABES) · doi:10.70675/89efde8dzf329z4c08zad57z08ffd23d7992
Caractérisation et modélisation des pathologies lymphoïdes présentant des gains du chromosome 21
Laurent, A. P. (2019) · theses.fr (ABES) · doi:10.70675/ed87382fza9bcz45fdz8589zd8c7fb99d3a9
Modélisation de la leucémie aiguë lymphoblastique B induite par la mutation PAX5 P80R
Bayet, M. (2024) · theses.fr (ABES) · doi:10.70675/97cdd921z96e3z460bz87e2zbbaa0d038360 · Cited by 1
Kittaneh, H., Castiglione, F., Liso, A., & Jarrah, A. S. (2026) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2026.111714
Attarbaschi, A. (2026) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-026-01115-1
“…and molecular lesions such as review ETV6::RUNX1 rearrangement, high-hyperdiploidy (54–67 chromosomes), KMT2A rearrangements, BCR::ABL1 and other ABL class rearrangements, hy-podiploidy ( 45 chromosomes), and IKZF1 -driven profiles help to define prognosis and treatment intensity [4, 7–10].”
Jayousi, F., Kraus, F., Conrrero, A., Bush, J. W., Setiadi, A., & Lange, P. F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.27.747627
Olivier, K., Marais, A., Thompson, K., Badenhorst, A., Tennant, A., & Potgieter, J. (2026) · Journal of the Colleges of Medicine of South Africa · doi:10.4102/jcmsa.v4i1.432
Nigam, N., Matsukawa, T., Bertoli, R. M., Tremblay, M. L., Yin, M., 赵咏梅, Chung, Y. J., & Aplan, P. D. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag250
Prognostic factors in pediatric acute lymphoblastic leukemia
Ribeiro, A. R. S. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA. SYSTEMATIC REVIEW
Tashenova, G., Abdilova, G., Kairbaeva, D. N., Sarmoldina, A., Sabitova, R. F., Omarova, G., & Рабандияров, М. Р. (2026) · Ġylym men densaulyķ saķtau. · doi:10.34689/sh.2025.28.4.26
Metadata
- Authors
- Mullighan, C. G.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Mullighan, Charles G.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 10
- Pages
- 3407-3415
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3461902
- OpenAlex
- W2146473098
- Cited by
- 247
- References
- 127
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 12 · 2023: 10 · 2022: 15 · 2021: 17 · 2020: 22 · 2019: 21 · 2018: 15 · 2017: 30 · 2016: 32 · 2015: 16 · 2014: 20 · 2013: 17 · 2012: 1
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- American Society of Hematology
- St. Jude Children's Research Hospital
- American Lebanese Syrian Associated Charities (38105)
- Children’s Oncology Group
- Stand Up To Cancer
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- B-cell precursor acute lymphoblastic leukemia, somatic alterations, chromosomal rearrangements, aneuploidy, prognosis, leukemogenesis, genetic profiling, childhood cancer
- MeSH terms
- Adult, Animals, B-Lymphocytes, Child, Clone Cells, Hematopoietic Stem Cells, Humans, Neoplasm Proteins, Prognosis, Risk, Translocation, Genetic, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Oncogene Proteins, Fusion, Mice, Knockout, Cell Lineage, Genetic Predisposition to Disease, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.